Monday, September 23, 2019

Latest:

Do no harm: A moral imperative to be the change in healthcare
Early postnatal overnutrition sets the body on a fast track to aging
Recipe: Roasted root vegetables make for simple, healthy side dish
Teens and social media: Tips to encourage responsible use
What to expect within the tumor microenvironment

Baylor College of Medicine Blog Network

Momentum
From The Labs
- About From the Labs
- Follow From The Labs on Twitter
PolicyWise
- About PolicyWise
- Follow @BCMEthics on Twitter
Progress Notes
- About Progress Notes
- Connect With Us
bcm.edu

TapImmune

From The Labs

From the labs to commercialization: Companies merge to implement Baylor College of Medicine-developed therapies for cancer

August 16, 2018August 16, 2018 Ana Rodríguez 0 Comments cancer therapy, commercialization, Marker Therapeutics, Research, T cells, TapImmune, tumor cells

Despite major advances in cancer therapy, conventional cancer treatments continue to be associated with devastating side effects for patients and

From the Labs features a soil-dwelling amoeba interacting with bacteria. Learn what happens to these amoebae in the absence of lectin.

Listen to the Body of Work Podcast

Body of Work, the Baylor College of Medicine podcast, is an exploration of health topics in the news and important scientific matters featuring insights from experts at Baylor. Listen on your preferred platform.